Using these ANO1-depleted cells, we examined whether the reactivation of ANO1 in response to 5-Aza-CdR treatment could influence the migratory and invasive abilities of prostate cancer cells, which are considered as critical determinants for metastatic cell dissemination. Here, ANO1 is linked to prostate cancer.